ATE286396T1 - Kombination der nikotinsäure oder nikotinamid mit riboflavin für die behandlung der pruritus und entzündungstörungen - Google Patents

Kombination der nikotinsäure oder nikotinamid mit riboflavin für die behandlung der pruritus und entzündungstörungen

Info

Publication number
ATE286396T1
ATE286396T1 AT00935465T AT00935465T ATE286396T1 AT E286396 T1 ATE286396 T1 AT E286396T1 AT 00935465 T AT00935465 T AT 00935465T AT 00935465 T AT00935465 T AT 00935465T AT E286396 T1 ATE286396 T1 AT E286396T1
Authority
AT
Austria
Prior art keywords
pruritus
treatment
riboflavin
nicotinamide
combination
Prior art date
Application number
AT00935465T
Other languages
English (en)
Inventor
Giampiero Valletta
Original Assignee
Giampiero Valletta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giampiero Valletta filed Critical Giampiero Valletta
Application granted granted Critical
Publication of ATE286396T1 publication Critical patent/ATE286396T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00935465T 1999-05-17 2000-05-17 Kombination der nikotinsäure oder nikotinamid mit riboflavin für die behandlung der pruritus und entzündungstörungen ATE286396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000309A IT1306141B1 (it) 1999-05-17 1999-05-17 Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
PCT/IT2000/000196 WO2000069426A2 (en) 1999-05-17 2000-05-17 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders

Publications (1)

Publication Number Publication Date
ATE286396T1 true ATE286396T1 (de) 2005-01-15

Family

ID=11406769

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00935465T ATE286396T1 (de) 1999-05-17 2000-05-17 Kombination der nikotinsäure oder nikotinamid mit riboflavin für die behandlung der pruritus und entzündungstörungen

Country Status (12)

Country Link
US (2) US7026319B1 (de)
EP (1) EP1178801B1 (de)
JP (1) JP2002544225A (de)
CN (1) CN1159013C (de)
AT (1) ATE286396T1 (de)
AU (1) AU774343B2 (de)
CA (1) CA2373296C (de)
DE (1) DE60017251T2 (de)
EA (1) EA003792B1 (de)
ES (1) ES2233384T3 (de)
IT (1) IT1306141B1 (de)
WO (1) WO2000069426A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1320776B1 (it) * 2000-08-07 2003-12-10 Giampiero Valletta Composizione farmaceutica a base di un'associazione vitaminica per laterapia delle cefalee primarie
PT1365762E (pt) * 2001-03-08 2008-11-27 Univ Kentucky Res Found Processo para aumentar os níveis de leptina utilizando compostos do ácido nicotínico
AR041089A1 (es) * 2003-05-15 2005-05-04 Merck & Co Inc Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
US20040254202A1 (en) * 2003-06-13 2004-12-16 The Procter & Gamble Company Method of promoting sleep using topical administration of vasoactive agents
US20100260841A1 (en) * 2007-02-08 2010-10-14 Paolini John F Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions
WO2009118371A1 (en) * 2008-03-28 2009-10-01 Janssen Pharmaceutica Nv Use of nicotinamide for treating summer itch in horses
US8128949B2 (en) * 2008-04-14 2012-03-06 John Mosher Kit for insect bites
KR20180021280A (ko) * 2016-08-18 2018-03-02 한양대학교 산학협력단 리보플라빈을 포함하는 가려움증 억제 또는 완화용 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096712A1 (en) * 1970-06-29 1972-02-25 Giraux Georges Steroid/b group vitamin compsns - for prevention and treatment of skin-photosensitivity disorders
US4265887A (en) * 1979-12-11 1981-05-05 Breskman Joseph S Composition and method for treatment of hemorrhoids
WO1984001899A1 (en) 1982-11-16 1984-05-24 Georges Motschan New utilization of a unique vitamin or a combination of various vitamins
US5053396A (en) * 1985-08-27 1991-10-01 Blass David H Therapeutic composition
JPS63188627A (ja) * 1987-01-31 1988-08-04 Rooto Seiyaku Kk 抗アレルギ−・抗炎症剤
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
CN1080855A (zh) 1993-05-22 1994-01-19 黎均耀 维生素矿物质防癌复方
DE4410238A1 (de) * 1994-03-25 1995-09-28 Beiersdorf Ag Hautpflegemittel
US5496827A (en) * 1994-07-15 1996-03-05 Patrick; Jay Compositions for the transdermal delivery of nutrients
PT839211E (pt) * 1995-07-13 2001-10-30 Forschungszentrum Juelich Gmbh Processo para a preparacao de riboflavina por meio de microorganismos com actividade de isocitratoliase modificada
US6028111A (en) * 1996-03-08 2000-02-22 Oxigene, Inc. Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
US6248763B1 (en) * 1998-05-19 2001-06-19 Scivoletto Rosemarie Composition for treating skin conditions
CN1120000C (zh) * 1997-11-24 2003-09-03 曾忠铭 刺激阴道革兰氏阳性杆菌生长、增强阴道酸度的药剂和其用途
CN1188107C (zh) * 1998-03-16 2005-02-09 宝洁公司 调节皮肤外观的组合物

Also Published As

Publication number Publication date
US7291625B2 (en) 2007-11-06
CN1159013C (zh) 2004-07-28
DE60017251D1 (de) 2005-02-10
DE60017251T2 (de) 2005-12-15
US20060178368A1 (en) 2006-08-10
EA003792B1 (ru) 2003-10-30
AU5100300A (en) 2000-12-05
CA2373296A1 (en) 2000-11-23
ES2233384T3 (es) 2005-06-16
WO2000069426A2 (en) 2000-11-23
ITRM990309A1 (it) 2000-11-17
ITRM990309A0 (it) 1999-05-17
IT1306141B1 (it) 2001-05-30
WO2000069426A3 (en) 2001-04-12
EA200101205A1 (ru) 2002-04-25
EP1178801A2 (de) 2002-02-13
US7026319B1 (en) 2006-04-11
AU774343B2 (en) 2004-06-24
JP2002544225A (ja) 2002-12-24
EP1178801B1 (de) 2005-01-05
CA2373296C (en) 2008-07-15
CN1350455A (zh) 2002-05-22

Similar Documents

Publication Publication Date Title
DE19882573T1 (de) Verwendung von Kombinationen mit nicht-sedierenden Antihistaminen und alpha-adrenergen Arzneistoffen für die topische Behandlung von Rhinitis/Konjunktivitis sowie Erkältungen, erkältungsähnlichen Symptomen und Grippesymptomen
DE602005009745D1 (de) Glucopyranosyl-substituierte benzen-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
NO20050662L (no) COX-2 inhiberende pyridinderivater
BR0314059A (pt) Compostos heterocìclicos
DE60305052D1 (de) Thienopyrrolyl und furanopyrrolyl verbindungen und deren verwendung als histamin h4 rezeptor liganden
MY142804A (en) Nk1 antagonists
DK1474395T3 (da) Nicotinamidderivater, der er nyttige som p38-inhibitorer
DE60334015D1 (de) Pyridopyrrolizin- und pyridoindolizinderivate
NO20062417L (no) N-tiazol-2-yl-benzamidderivater
NO20054200L (no) Pyrazoler samt fremgangsmate for fremstilling derav
ATE422198T1 (de) Arylsulfonylnaphthalinderivate als 5ht2a- antagonisten
ECSP055809A (es) Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4
NO20052796L (no) Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese
DE602006008456D1 (de) Amylin und amylinagonisten für die behandlung von psychiatrischen erkrankungen und störungen
DE60215000D1 (de) DIHYDROPYRROLOi1,2-AöINDOL- UND TETRAHYDROPYRIDOi1,2-AöINDOLDERIVATE ALS PROSTAGLANDIN REZEPTOR ANTAGONISTEN
DK2298743T3 (da) p38-Kinaseinhibitorer på grundlag af en 5-leddet heterocyclisk ring
NO20073366L (no) 1,6-substituert (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-2,5-piperazindionderivater som oksytocinreceptorantagonister for behandling av for tidlige veer, dysmenorri og endometriose
WO2005066139A3 (en) 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases
NO20070855L (no) Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer.
ATE286396T1 (de) Kombination der nikotinsäure oder nikotinamid mit riboflavin für die behandlung der pruritus und entzündungstörungen
NO20063300L (no) Fremgangsmater for behandling av akutt inflammasjon i dyr med p38 MAP kinaseinhibitorer
NO20063576L (no) 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes
MXPA05002443A (es) Pirazolopiridinas y metodos para elaboracion y uso de las mismas.
NO20071805L (no) Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere.
NO20082297L (no) Piperazinderivater som er anvendelige som CCR5-antagonister

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1178801

Country of ref document: EP